darunavir 675 MG (as darunavir ethanolate ) / cobicistat 150 MG Oral Tablet

RxCUI
2710424
RxNorm name
darunavir 675 MG (as darunavir ethanolate ) / cobicistat 150 MG Oral Tablet
Display name
darunavir 675 MG (as darunavir ethanolate ) / cobicistat 150 MG Oral Tablet
Full name
darunavir 675 MG (as darunavir ethanolate ) / cobicistat 150 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PREZCOBIXDARUNAVIR ETHANOLATE AND COBICISTATJanssen Products, LP9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f2026-02-01Warnings, Adverse reactionsExact identifier
rxcui: 2710424

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9fdarunavir 675 MG (as darunavir ethanolate ) / cobicistat 150 MG Oral TabletSY28These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 201520260201
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9fdarunavir 675 MG / cobicistat 150 MG Oral TabletPSN28These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 201520260201
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9fcobicistat 150 MG / darunavir 675 MG Oral TabletSCD28These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 201520260201